Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
236.50    0.00 (0.00%)
Bid:
236.00
Ask:
247.50
Spread: 11.50 (4.873%)
Market Cap: £137.96m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Covid-19 Update

6 Apr 2020 07:00

RNS Number : 8184I
MJ Gleeson PLC
06 April 2020
 

MJ Gleeson plc (GLE.L)

("Gleeson" or "the Company")

 

 6 April 2020

Update on corporate actions in response to Covid-19

Further to the announcement of 25 March 2020 the Company has moved swiftly to put in place a number of further actions to mitigate the impact of the pandemic.

With immediate effect:

· A total of 456 employees, representing 76% of the workforce will be furloughed in-line with the Government's Job Retention Scheme and with the Company topping-up salaries of those affected up to a minimum of 80% and a maximum of 95% of salary.

· All members of the Board are taking a reduction in salary/fees of 30%.

· Senior management are taking reductions in salary of between 5% and 20%, weighted according to salary bands.

· The Company will review the position at the end of May.

Together with the actions already taken including cancellation of the interim dividend, pausing all build activity and land acquisition, cutting discretionary costs and implementing a recruitment freeze, the Company has now implemented a comprehensive range of actions to ensure that it is well placed to restart operationally once conditions allow.

A key priority is to reopen sites and sales offices once it is appropriate and safe to do so and our focus now turns to putting in place a programme to ensure as efficient a re-start as possible immediately the resumption of trading is permitted.

We are keen to work with central government and local authorities to agree what provisions might be put in place to enable the safe resumption of building much-needed quality affordable homes as soon as it is practicable to do so.

Gleeson builds and sells high quality, low-cost 2, 3 and 4 bedroom homes to first time buyers on average and lower incomes across the Midlands and North of England, areas where there are already acute supply shortages. The current situation is further exacerbating this position.

Two-thirds of the homes we sell are to people in what are now designated Key Worker roles. In recognition of their extraordinary efforts in keeping us all safe, fed and healthy the Board has decided that, when the Company is able to recommence site build activities, it will prioritise house sales to Key Workers.

The Board continues to monitor the rapidly-evolving situation and investigate a number of additional measures should they be required.

ENDS

Enquiries:

Instinctif Partners

 

Mark Garraway 07771 860938

James Gray 07814 379412

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEAELSEELEEAA
Date   Source Headline
10th Feb 20227:00 amRNSHalf-year Report
8th Feb 20224:20 pmRNSDirector/PDMR Shareholding
11th Jan 20224:38 pmRNSDirector/PDMR Shareholding
11th Jan 20227:00 amRNSNotice of Results & Trading Update
31st Dec 20217:00 amRNSTotal Voting Rights
8th Dec 20212:47 pmRNSDirector/PDMR Shareholding
30th Nov 20217:00 amRNSTotal Voting Rights
26th Nov 20214:50 pmRNSDirector/PDMR Shareholding - Amendment
26th Nov 20214:49 pmRNSDirector/PDMR Shareholding
15th Nov 202112:52 pmRNSResult of AGM
15th Nov 20217:00 amRNSAGM Statement
8th Nov 20211:50 pmRNSDirector/PDMR Shareholding
4th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20218:29 amRNSDirector/PDMR Shareholding
29th Oct 20217:00 amRNSTotal Voting Rights
26th Oct 20219:38 amRNSDirector/PDMR Shareholding
15th Oct 20214:41 pmRNSSecond Price Monitoring Extn
15th Oct 20214:36 pmRNSPrice Monitoring Extension
13th Oct 202112:48 pmRNSNotice of AGM
8th Oct 20211:22 pmRNSDirector/PDMR Shareholding
1st Oct 20217:00 amRNSPerformance Share Plan award to PDMRs
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20214:09 pmRNSPerformance Share Plan award to Directors
28th Sep 20214:06 pmRNSDirector/PDMR Shareholding
15th Sep 202110:33 amRNSDirector/PDMR Shareholding - Amendment
14th Sep 20217:00 amRNSAudited results for the year ended 30 June 2021
8th Sep 202111:14 amRNSDirector/PDMR Shareholding
31st Aug 20217:00 amRNSTotal Voting Rights
9th Aug 20214:37 pmRNSPrice Monitoring Extension
9th Aug 20211:11 pmRNSDirector/PDMR Shareholding
30th Jul 20217:00 amRNSTotal Voting Rights
21st Jul 20217:00 amRNSLong Term Incentive Plan award to Director
9th Jul 20219:41 amRNSDirector/PDMR Shareholding
9th Jul 20217:00 amRNSNotice of Results & Trading Update
7th Jul 20214:47 pmRNSDirector/PDMR Shareholding
30th Jun 20217:00 amRNSTotal Voting Rights
8th Jun 20214:44 pmRNSDirector/PDMR Shareholding
28th May 20217:00 amRNSTotal Voting Rights
24th May 20217:00 amRNSTrading Update
7th May 20214:33 pmRNSDirector/PDMR Shareholding
30th Apr 20217:00 amRNSTotal Voting Rights
9th Apr 20212:02 pmRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSTotal Voting Rights
26th Mar 20214:08 pmRNSRe Committee appointments
22nd Mar 20218:34 amRNSPerformance Share Plan award to Directors/PDMRs
8th Mar 20211:44 pmRNSDirector/PDMR Shareholding
1st Mar 20217:00 amRNSRe Directorate
26th Feb 20217:00 amRNSTotal Voting Rights
11th Feb 20217:00 amRNSHalf-year Report
8th Feb 20215:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.